Skip to content

Artificial Induction of Labour in Full-term Singleton Pregnancy : Comparative Randomized Trial of Two Strategies

Artificial Induction of Labour in Full-term Singleton Pregnancy : Comparative Randomized Clinical Trial of Two Strategies (DINO-FIRST Versus BALLON-FIRST)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04452747
Acronym
BESTWAY
Enrollment
450
Registered
2020-06-30
Start date
2020-11-16
Completion date
2023-03-01
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy Related

Brief summary

Labour induction is an obstetrical procedure, which artificially starts the process of cervix dilation, in order to induce labour. Several methods of labour induction exist : mechanical ones (using dilatation balloons) or pharmacological ones (using prostaglandins or oxytocin). This trial aims to compare, in case of non-favourable cervix, the strategy of labour induction using the Propess® method first (Dino-first) versus the strategy beginning with the use of a dilatation balloon (Ballon-first), with respect of the usual practice and the current guidelines.

Interventions

PROCEDUREVaginal Dinoprostone system (Propess®)

Labour will be induced using the vaginal Dinoprostone system (Propess®) as a first strategy

PROCEDUREDilatation balloon

Labour will be induced using a cervix dilatation balloon as a first strategy

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Women with singleton pregnancy * Fetus with cephalic presentation * Intact membranes between 37 and 42 weeks of amenorrhea * Medical indication for labour induction according to the Haute Autorité de Santé (HAS) guidelines * Unfavourable cervix (Bishop scoring \< 7) * Age \> 18 years-old * Person affiliated to a healthcare system * Good understanding of the French language

Exclusion criteria

* Previous C-section or uterine incision * Placenta previa * Metrorrhagia of unknown origin * Lethal foetal abnormality * Hyperreactivity to one of the molecules used for the induction (dinoprostone or oxytocin) or to latex * Subject participants to another biomedical research * Subject under legal guardianship or curatorship

Design outcomes

Primary

MeasureTime frameDescription
Rate of vaginal deliveriesOn the day of the deliveryRate of vaginal deliveries (both spontaneous or instrumentally assisted)

Secondary

MeasureTime frameDescription
Rate of instrumentally assisted vaginal deliveries, including the reason for the assistanceOn the day of the deliveryNumber of instrumentally assisted vaginal deliveries, including the reason for the assistance
Rate of C-section including the reason for the C-sectionOn the day of the deliveryNumber of C-section including the reason for the C-section. The reasons for the C-section can be : a failure of dilatation at the first stage of the labour (between 0 and 10 cm), an absence of foetal descent at the second stage of labour, a foetal reason or a maternal reason)
Timeframe between the beginning of the induction and the beginning of the labourOn the day of the deliveryTime elapsed between the beginning of the induction and the beginning of the labour
Cumulated rate of spontaneous vaginal deliveriesat 12 hours, 24 hours and 48 hoursCumulated number of spontaneous vaginal deliveries at 12 hours, 24 hours and 48 hours
Rate of labour induction failureOn the day of the deliveryRate of labour induction failure is measure by the number of C-sections carried out due to a latency phase (0-6cm), which lasted more than 24 hours, together with the administration of oxytocin for at least 12 to 18 hours after the membranes artifically broke.
Rate of secondary or tertiary use of Propess, Foley catheter of intra-veinous oxytocinOn the day of the deliveryNumber of secondary or tertiary use of Propess, Foley catheter of intra-veinous oxytocin
Rate of peridural anaesthesia during labourOn the day of the deliveryNumber of peridural anaesthesia during labour
Rate of uterine hyperstimulation without impact on the foetusOn the day of the deliveryUterine hyperstimulation is described as a number of contractions of 6 or more within 10 minutes, repeating at least twice). Foetal impact is defined as a slowing of the foetal heart rate.
Rate of uterine hyperstimulation with an impact on the foetusOn the day of the deliveryUterine hyperstimulation is described as a number of contractions of 6 or more within 10 minutes, repeating at least twice). Foetal impact is defined as a slowing of the foetal heart rate.
Rate of uterine hypertoniaOn the day of the deliveryUterine hypertonia is describes as a frequency of contractions every 2 minutes or less together with a slowing of the foetal heart rate.
Rate of post-partum haemorrhagiaOn the day of the deliveryRate of post-partum haemorrhagia above 500 mL, above 1000 mL, transfusion level and number of packed red blood cells transfused
Rate of spontaneous vaginal deliveriesOn the day of the deliveryNumber of spontaneous vaginal deliveries
Rate of intra-uterine infectionsOn the day of the deliveryNumber of patients with intra-uterine infections (body temperature above 38°C measured twice within 30 minutes, associated to 2 criteria within the followings: foetal tachycardia above 160 beats per minute, pain of the uterus or painful uterus contractions ou spontaneous labour induction, or purulent amniotic fluid.
Rate of post-partum infectionsOne week after day of the deliveryNumber of patients with post-partum infections (body temperature above 38°C with antibiotic treatment, urinary tract infections, bacteriological endometritis)
Rate of neonatal asphyxiaOn the day of the deliveryNumber of fetuses with neonatal asphyxia
Rate of hospitalization in Neonatal intensive care unitUp to four days after the deliveryNumber of newborn babies hospitalized in Neonatal intensive care unit
Rate of proven bacteriological infections in newborn babiesUp to four days after the deliveryNumber of proven bacteriological infections in newborn babies
Rate of metrorrhagias while putting in place the dilatation balloon or the vaginal pad (dinoprostone)On the day of the deliveryNumber of women who experienced metrorrhagias while putting in place the dilatation balloon or the vaginal pad (dinoprostone)
Pain level linked to the inflation of the dilatation balloon and requiring the partial deflation of the balloonOn the day of the deliveryMeasurement of Pain will be made using an Visual Analog Scale (VAS). The pain level will be linked to the inflation of the dilatation balloon and requiring the partial deflation of the balloon
Pain level recorded at different times of the labour inductionOn the day of the deliveryMeasurement will be made using a Visual Analog Scale (VAS) and will be recorded at different times of the dilatation balloon or the dinoprostone vaginal pad set up
Assessment of the patient experience of the labour inductionUp to two weeks after the deliveryPatient experience will be assessed using the W-DEQ (Wijma Delivery Expectancy/Experience Questionnaire)
Assessment of each strategy direct main coststhrough study completion, an average of 3 yearsThe costs of the treatment and duration of the hospitalization will be measured
Rate of uterine ruptureOn the day of the deliveryNumber of patients with a uterine rupture

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026